PR Hub

Stemgent Inc.

New Venture co-founded with Professor Sir Philip Cohen to Focus on the Ubiquitin Proteasome Pathway, a Key Cell Signalling System with Significant Drug Discovery Potential


BOSTON and SAN DIEGO, March 3, 2010 - Stemgent, Inc., a biotechnology company based in San Diego, California, and Boston, Massachusetts, USA, announced today the formation of Ubiquigent Ltd, a new biotechnology company based in Dundee, Scotland.
MORE..
Older News
S M T W T F S
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
Copyright© 2010 The Gaea Times